Purchase Order 75D30123P17658
Award Date
8/22/23
Potential Completion Date
8/20/28
Potential Value
$54K
Federal Agency
CDC Pittsburgh
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions, with a potential value of $159,999.10. The contract has a completion date of September 14, 2023 and was awarded on September 15, 2022. Illumina has previously received federal contract awards from agencies such as the NIH, USDA, and VA to provide a range of sequencing systems, reagents, and...
The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $247,008.03 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing and analysis products. The contract is for the provision of laboratory supplies, with a completion date of May 31, 2024. Illumina has previously received federal awards from agencies such as the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $107,368.22 firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the provision of WDPB ILLUMINA LAB SUPPLIES, to be delivered by September 30, 2022. Illumina has a history of providing sequencing systems, reagents, and other supporting products and services to various federal agencies, including...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $22,376.85 contract is for the provision of an ISEQ 100 SYSTEM, with a completion date of March 1, 2026. This award does not have a set-aside designation. Illumina has previously received prime federal contracts from agencies such as the NIH,...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $144,302.41 contract provides supplies - chemicals to support the agency's research and diagnostics needs. This award does not have a set-aside designation. Illumina has previously been awarded prime federal contracts by agencies such as NIH, USDA,...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The $83,968.67 contract is for the provision of unspecified goods and services, with no set-aside designation. Illumina has a history of providing sequencing systems, consumables, and related services to federal agencies like the NIH, USDA, and VA for genomic research and diagnostic applications....
The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for reagents to be used with Illumina's sequencing systems. The $219,192.00 contract does not have a set-aside designation and is intended to support the CDC's needs through August 31, 2022. Illumina has a history of providing sequencing equipment, consumables, and services to...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents, for the procurement of a NEXTSEQ 1000 SEQUENCING SYSTEM. The total potential value of the award is $205,800.00 with a completion date of August 23, 2021. Illumina has a history of providing sequencing equipment, consumables, and services to federal agencies such as the National...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a manufacturer of genetic and genomic analysis equipment and reagents. The $95,931.00 contract is for the delivery of laboratory equipment with no set-aside designation. Illumina has a history of providing sequencing instruments, reagents, and related services to support genomic research and diagnostics across federal agencies such as the...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, for ILLUMINA ISEQ 100 I1 REAGENT. The potential value of this contract is $9,991.97. This award is not associated with any larger contract vehicle and does not have a set-aside designation. Illumina has previously provided sequencing systems, reagents,...